02/04/2019 - 10:42

MGC has goal posts firmly in sight

02/04/2019 - 10:42

Bookmark

Save articles for future reference.

MGC Pharmaceuticals continues to progress its strategy to commercialise its bio-pharma business with research partner RMIT receiving approval from the Australian Office of Drug Control to possess and handle phytocannabinoids for research purposes. The company has also been awarded a European Union licence to produce non-sterile schedule two medicines in that jurisdiction.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options